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DOI 10.1186/s12902-017-0196-0RESEARCH ARTICLE Open AccessExploration of knowledge and
understanding in patients with primary
adrenal insufficiency: a mixed methods
study
L. M Shepherd1,2*, A. A Tahrani1,2,4, C Inman3, W Arlt2,4 and D. M Carrick-Sen5,6Abstract
Background: Primary adrenal insufficiency (PAI) is a rare and severe condition requiring lifelong steroid replacement.
During acute illness or stressful events, it is important to appropriately adjust glucocorticoid dose; failure to do so may
lead to an adrenal crisis. The aim of the study was to explore patients PAI knowledge and understanding of the
condition, steroid replacement adjustment during acute illness or stress and provided education.
Methods: Ten adult patients with PAI were purposefully recruited from two hospitals in a tertiary NHS Trust in
England, UK. Data was collected using a mixed method approach utilising semi-structured audio-recorded
interviews and hospital case note review. Interviews were transcribed verbatim and analysed using Burnard’s
content analysis framework. Information from the hospital case note review was captured using a matrix table
based on pre-defined criteria.
Results: Four key themes emerged: ‘Addison’s disease and hydrocortisone replacement’; ‘stress and corticosteroids’;
‘patient compliance/adherence’ and ‘transition’. Patients reported feelings of ‘going through a transition from
uncertainty to adaption’ following diagnosis. All participants had a good level of knowledge and understanding
of required medication however application in times of need was poor. Medication adherence and prevention of a
crisis relied not only on patient knowledge and application but also the support of family and health professionals.
Health care professional knowledge required improvement to aid diagnosis and management of PAI.
Conclusion: Patients with PAI did not apply existing knowledge to adjust steroid dose during acute illness or stress.
Although a sample of limited size, our study identified there is a need to further explore why patients with Addison’s
disease do not apply existing knowledge during times of increased need. Future research should consider appropriate
behaviour change interventions to promote medication adherence to reduce risk of an adrenal crisis.
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Primary adrenal insufficiency (PAI) or Addison’s disease
is a life threatening endocrine condition, where the
destruction of the adrenal cortex, most commonly via
an autoimmune mechanism results in inadequate pro-
duction of glucocorticoids, mineralocorticoids and an-
drogens [1]. The prevalence of PAI is 10–22 per 100,
000 [2, 3] and an incidence of 4–6 per million per
year [4, 5].
In times of acute illness, for example flu like illness
and fever, patients need to increase their glucocorticoid
dose to mimic physiological changes in cortisol secretion
during stress [6, 7]. The occurrence of adrenal crisis in
PAI has been reported as 5.2–8.3 crisis/100 patient years
[6–8]. About 55% of women and 52% of men reported
one or more adrenal crises since diagnosis [7]. Whilst
those who have experienced a previous adrenal crisis are
at greater risk of a subsequent episode [6, 7].
PAI is a chronic condition requiring adherence and
appropriate adjustment of medication in times of
need to prevent an adrenal crisis and hospital admis-
sion [6, 7]. Adherence and adjustment of medication
is linked to patients knowledge and understanding.
Within other chronic conditions like diabetes, adequate
knowledge and understanding has been shown to
increase medication adherence [9]. In PAI, health pro-
fessional and patient guidance is available regarding
the adjustment of steroids during acute illness and
stress [2, 10]. However, there is limited available evi-
dence of level, comprehension and application of
knowledge in patients with PAI. Furthermore, it has
been identified that adrenal crisis still occurs even in
patients with chronic adrenal insufficiency who have
been educated [6].
Hence, the aims of our study were to explore if
patients with PAI have sufficient knowledge and under-
standing of the condition; knowledge of how and when
to adjust steroid replacement during acute illness or
stressful event; and been provided with the required
information.
Methods
A mixed method study was conducted involving qualita-
tive semi-structured interviews and review of participant’s
health care records. Qualitative researchers utilising inter-
views seek to understand rather than explain [11] and
focus on the illumination of data through the subjects in-
terpretation of their circumstance.
Sample/participants
Pragmatic purposive sampling was adopted from two
different demographic location hospitals in a single
tertiary NHS Trust in UK. It was planned to recruit
up to 15 participants, or until data saturation wasachieved [12, 13]. It has been posited by Guest et al.
(2006) that data saturation occurs by the time 12 in-
terviews have been analysed [13]. Therefore the
planned recruitment number allowed for attrition and
allowed for further data to be gathered until data
saturation was achieved. However, data saturation oc-
curred at the point when ten patients had participated
in the study.
Patients were approached in the waiting area of the
endocrine clinic when attending their appointment by a
health professional/receptionist who was not involved
with the research and were provided with a patient
information sheet. They contacted the researcher at a
later date if they were interested in participating. Inclu-
sion criteria included; participants 18 years old or over,
English speaking and with an established diagnosis of
PAI based on endocrinologist diagnosis, and usually
administers their own medication. The leading author is
an endocrine specialist nurse at the centre and hence
she was known to the patients.
Data collection
Individual face-to-face, semi structured interviews and
review of participant’s health care records were carried
out by the first author in this study. Prior to commence-
ment of the interview discussion took place of the pur-
pose of the study, participant involvement and consent
was attained. The right to withdraw at any time was
reiterated. Interviews lasted up to 60 min and were con-
ducted at a location of the participant’s choice. A
conversational interview technique was utilised with
the aid of a semi structured interview guide (Table 1)
as recommended by Holloway & Wheeler [14]. An
interview guide was developed from key themes in the
literature and from the clinical researchers’ experience
in the field. This interview guide allowed flexibility to
accommodate new topics and concepts introduced by
the participants [14].
All participant health care records were retrospect-
ively reviewed to assess if there was documented evi-
dence of education provided from endocrinologists and
endocrine specialist nurses including; sick day rules,
provision of steroid card, wearing of medic alert jewel-
lery and possession of emergency hydrocortisone injec-
tion kit (Table 2).
Data analysis
Guidance on the data analysis was based on Burnard’s
[15, 16] thematic content analysis framework. This in-
volved a stepped process of identifying themes and cat-
egories that ‘emerge from the data’ [16]. Analysis of the
data involved utilising steps one to ten.
The structure of Burnard’s data analysis led the reduced
final categories, sub categories shown in (Table 3) with
Table 1 The interview guide
The following questions were used as an interview guide. Commencing
with an icebreaker, questions may be asked in a different order, omitted
or added depending on participants’ responses.
1. How long have you had Addison’s disease? Tell me more. Diagnosed
when and how? Medication?
2. Have you been advised what to do with your medication in times of
stress/illness? Who gave the advice? When? Give me examples what
you would do when you experience
-a cold
-a temperature
-an infection
-diarrhoea
-vomiting
-psychological distress, e.g. car accident without injury, bereavement
-surgery
-dental treatment
3. Have you ever been advised to stop your steroids? By whom? When?
4. Have you ever been advised to carry or wear anything stating your
illness/medication?
5. Have you ever been in contact with a support group? What information/
advice did they give you?
6. Do you have an emergency hydrocortisone injection kit? Have you
ever needed to use this? If not, is this something you would consider
having?
7. Have you ever had an Addisonian crisis? Tell me what happened?
What precipitated this? What happened when you got to hospital?
8. What education/advice would you like to have had when diagnosed?
On a regular basis?
9. Do you have to take anything into account about your illness if you
are going on holiday?
10. Is there anything else you would like to talk about/add?
Table 2 Documented evidence of education
Participant
number
Documentation
of sick day rules
Steroid
card
Medical
identification
jewellery
Emergency
hydrocortisone
injection kit
1 Y Y Y N
2 Y N Y N
3 Y Y N N
4 Y Y N Y
5 Y Y Y Y
6 Y Y Y N
7 Y Y Y Y
8 N N N N
9 N N N N
10 Y Y N N
‘Y’ = Yes patient was given information; ‘N’ = no information was not provided
to patient
Table 3 Final categories and subcategories
Categories Subcategory
Addison’s Disease & Replacement Signs & symptoms
Crises
Unwanted effect of medication
Associated conditions
Stress & Corticosteroids Adjustment of medication
Emergency injection kit
Emergency identification
Stopping steroids
Patient adherence Education
Support systems-
Family
Professional
Voluntary
Transition Reeling
Dealing
Healing
Shepherd et al. BMC Endocrine Disorders  (2017) 17:47 Page 3 of 10corresponding examples of verbatim transcript. During
data analysis it became evident that no new categories or
sub categories were being identified and that data satur-
ation had been achieved, and subsequently recruitment
concluded at 10 participants [13].Rigour of data collection
In order to improve rigour the principles of trustworthiness
as described by Lincoln & Guba, Holloway & Wheeler and
Polit & Beck were adopted [14, 17, 18]. Dependability of
the interviews was enhanced by the use of an interview
guide that was developed based on relevant literature. With
regard to credibility, the first author reconfirmed the con-
tent of the interview with the participant to determine
accuracy of understanding and allowed them to add further
data to complement the researchers understanding, along
with the utilisation of participants verbatim quotes [14].
Field notes were maintained regarding setting and partici-
pant. An auditable decision trail was maintained by docu-
menting raw data as well as sources of data generation and
analysis decisions [14]. Data gathered was peer reviewed
by academic supervisors at various stages of the research
process allowing for verification of the effectiveness of the
data collection procedure, comprehensiveness of descrip-
tions, inclusivity of samples and logic of arguments [19].Results
Two male and eight female participated in the study with
a mean age of 47 years (age range 21 to 63 years) and a
median duration of PAI of 19 years (range 3–46 years). All
were White Europeans. Seven participants had previous
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pants described their journey from diagnosis to present.
The results presented below leads with each of the
four categories as identified in (Table 3). Each one is in-
troduced, supported by verbatim quotes from participants
and accompanied by a commentary. The discussion with
previous literature follows the results section.
Category 1: Addison’s disease and hydrocortisone
replacement
Participants identified signs and symptoms of PAI prior
to diagnosis. This was predominately due to the severity
of symptoms experienced prior to diagnosis and/or
adrenal crisis. All of the respondents described the
length of time to diagnosis as a problem, receiving many
differential diagnoses, despite seeking medical attention
on several occasions prior to diagnosis. This is demon-
strated in the below verbatim quotes,
“…I used to go the football…and half way through the
first half I had to sit down. If I used to go the pub I used
to have to sit down…I was too tired to stand up.” (P5).
“I just kept looking at them thinking why are my
hands brown. Why are these brown on me?” (P6).
“The Doctor did a glandular fever test which was
clear and then he decided I was depressed.” (P1).
“…they kept saying it was the effect of septrin or was
I pregnant or had I got anorexia (laughter) and all
sorts of different things…” (P7).
Seven out of ten participants affirmed they had experi-
enced an adrenal crisis since diagnosis and required
intravenous or intramuscular hydrocortisone and/or
hospitalisation.
“…I was getting to the stage I couldn’t talk to … because
my body was shutting down 'cause I was that bad…” (P1).
“…I was on the stretcher and they couldn’t get my
blood pressure in the ambulance…” (P3).
Participants described the unwanted effect of medi-
cation. Whilst participants were aware of potential side
effects of their medication they only spoke about the
effect steroids had on bone health.
“…osteoporosis which is obviously caused by the
steroids cause I’ve read up on that…” (P3).
Only three participants discussed associated condi-
tions of Addison’s disease with other autoimmuneconditions despite all participants having other auto-
immune conditions.
“…you’re thinking because it’s in the family of
diabetes, isn’t it you know? When you’ve got thyroid
and then diabetes and that, you’d think they’d catch it
easy…” (P6).
“…I didn’t know about the thyroid when I first had it
and diabetes and some of the other things.” (P7).
Category 2: Stress & corticosteroids
Participants discussed their understanding of the need to
adjust medication, which overall was very good. Nine
out of the 10 patients knew how to adjust their medication
in times of intercurrent illness. Medication intake was
bound to a prescribed rigid treatment regimen which
required rather complex and demanding self-care. How-
ever, length of time since diagnosis was not related to in-
creased knowledge as demonstrated in the verbatim quote
from participant 8.
“No, no, not at all. Funnily enough I did not realise
you could, you should or you needed to, to be
honest” (P8).
“…the only thing I've ever been told is if you’re abroad
on holiday and you have stomach problems you know,
if you have diarrhoea or something like that, then take
an additional tablet but that’s as much as I've been
told…”(P8).
“I’ll double them and then if I have a temperature or
anything else double it until the infections gone.” (P4).
Respondents informed HCPs of their condition, and
also relied upon them for advice and extra medication
during dental and surgical procedures. They saw the HCP
as the ‘expert’ and were guided by their recommendation,
even if they knew this to be incorrect.
“Yes I did have to tell them…when they knew I got
Addison’s disease they said that I would have to go
over night ‘cause I would have to have steroids
before I went into surgery. I’d have to stay in that
extra bit longer probably just as extra day to boost
me up…” (P9).
“I think it depends on which Doctor you see as
well. Like when I’ve been to clinic and I like to see
one Doctor now rather than each time I come to
clinic to see a different Doctor and they tell you
different things and I don’t think they know that
much about it…”(P7).
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cortisone injection kit but six expressed an interest in
having one.
“Major problems, yes, I would certainly use it if I was
taught how to use it…” (P8).
“I did have one when I was with the old doctor.” (P7).
Regarding emergency identification reassuringly all
study participants carried a steroid card and/or wore
medical information jewellery.
“Yes, when I was first diagnosed they wouldn’t let me
out of the hospital unless I got a bracelet.” (P7).
“I wear a meditag saying what’s wrong with me and
that I’m on steroids.” (P10).
Worryingly two participants had been advised to stop
taking their steroids either by a healthcare professional
or friend at some point since their diagnosis.
“…I couldn’t hold anything down, she [G.P] said don’t
worry it won’t hurt you to miss them for once cause
you’ve got bits of steroid going round your body… but
she shouldn’t have told me that.” (P6).
“…not medical people but other people said why
don’t you go to a homeopath. At the time I didn’t
realise…” (P10).
Category 3: Patient adherence
There was a noticeable difference in the quality and
quantity of education provided to participants on pre
and post diagnosis from healthcare professionals. Several
respondents felt they were given insufficient knowledge
and advice and indicated that they would have liked to
have received more information. None stated they received
an adequate amount.
“…when I got diagnosed I felt a bit as though I wasn't
told much about it…I had to go and find it myself…I
kept having to ask people.” (P6).
“…the consultant that diagnosed me at …said this
condition would have to be managed throughout my
life…” (P4).
Three support systems; family, healthcare profes-
sionals and voluntary were identified as important to,
and relied upon by, the participants. Family provided sub-
stantial support when it came to the management of the
participants’ condition and also when seeking a diagnosisfor the condition. The diagnosis was often only established
after perseverance from family in seeking medical help.
Whilst two participants felt their family should have a
better understanding of the condition, most participants
relied upon the opinion and assertiveness of family during
intercurrent illnesses. This was related to the administra-
tion of emergency treatment when seeking urgent medical
attention.”
“[At the hospital] … my husband said look I don’t
want it to go that far now, I want you to deal with it
now.” (P9).
“…if it weren’t for my Mom really I was just going to
lie here and die.” (P2).
Participants felt that rapport with the healthcare pro-
fessional contributed a major role in the support received.
However other participants felt they did not always
receive professional support.
“… he said I’ve never ever diagnosed or treated
anybody with Addison’s disease…” (P6).
“…it’s a lot easier have someone sit there you know.
It’s a bit strange isn’t it when you see a different
Doctor…” (P1).
Support from voluntary self-help groups was not always
seen as a priority by participants with only one being a
member, although some had accessed information
through the World Wide Web.
“I’ve looked on the internet though…yes and I’ve
printed off the first thousand pages (laughter)” (P5).
“I look it up on the internet; I’ve looked it up on
there.” (P7).
Category 4: Transition
Participants described a period of transition including
the psychological progression involved in adapting to
change, from pre diagnosis to their present situation going
through a process of ‘reeling’, ‘dealing’ and ‘healing’.
Participants described the first stage as ‘reeling.’
Chronic illness may cause a finale to a recognizable
existence represented by the time at which the diagnosis
of PAI was made. At this point participants tried to
establish ways of dealing with their condition, in order
for the diagnosis to be incorporated into their lives.
Participants felt disbelief and shock.-
“…when I was first diagnosed I did feel really, really
depressed.Why has this happened to me?” (P2).
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was going to affect the rest of my life…” (P4).
Participants experienced ‘dealing’ as a static stage and
during which time they reported feeling overwhelmed at
being different from others who did not have the
disorder. Respondents stated they felt isolated and alone,
thinking no one understood their experience and found
difficulty in explaining how they felt. It was a time of
self-absorption as the task was to try and reclaim them-
selves in the midst of change and to deal with the diag-
nosis and illness. Some chose to ignore their diagnosis
and others rejected offers of assistance during this time.
What became evident in this theme was the isolation felt
following diagnosis where participants sought to find
answers:
“…I remember thinking I wish I knew somebody else
who had it so they could tell me I’m going to be
alright and I can lead a relatively normal life…” (P9).
“…I used to write about six questions down and I’d go
in and ask these questions…” (P3).
Participants experience a healing stage when they felt
they had become ordinary again, even though the condi-
tion remained. Here the participants were more open to
learning from life and took action on issues that con-
fronted them. Therefore this stage demonstrated partici-
pants acceptance of the diagnosis and adaptation:
“…I say it’s the one thing in my life that I’m
comfortable with … You’ve just got to live with it and
that’s it really.” (P8).
“No it’s all pretty much get on normally really like it’s
I still cannot believe how two little tablets can make a
difference to the way you feel.” (P5).
Health care record review
Data was collected from participant’s health care records.
This included all available past and current healthcare
records which encompassed information from all health-
care consultations and typed correspondence to and from
the general practitioner. Quality of documentation varied
and was in the main legible but brief but overall inad-
equate. Table 2 illustrates the data collected from docu-
mented evidence of education from the health care record
review. The education was delivered by a combination of
endocrinologists and endocrine specialist nurses.
It was documented that eight participants had received
advice on ‘sick day rules’ during times of stress. Interest-
ingly, participant eight had said they received very min-
imal medication adjustment advice and this was notdocumented in their health care records. Participant
nine also had no documented evidence of ‘sick day rule’
advice, but reassuringly, demonstrated a good under-
standing of dose adjustment.
It was recorded that seven patients had steroid cards,
with no documentation stating that patient two, eight or
nine had been advised to carry one. However, encour-
agingly all participants were in possession of one.
Only six participants wore medical identification jew-
ellery and five had documentation that they had been
advised to wear it.
There was documented evidence that three partici-
pants were in possession of an emergency hydrocorti-
sone kit, although respondent seven no longer did so.
However, there was no evidence that the participants
had received any education on the preparation and
administration of this, or if they were deemed competent
to administer when required.
It is worth noting that it was the two participants that
had been diagnosed the longest duration, had least docu-
mentation in the notes.
Overall, documentation of sick day rules and posses-
sion of steroid cards was good.
Discussion
The study revealed that a majority of the interviewed
patients with PAI at this tertiary UK centre have good
knowledge and understanding of the condition. Al-
though the generalizability of the study is limited due
to the small sample size, the study demonstrated the
application of knowledge with regards to medication
adjustment in times of need is limited and concerning.
Further, participants describe their experience as a
transitional journey from pre diagnosis to present,
through three phases; reeling, dealing and healing.
Information obtained from health care records was
variable regarding confirmation of patient education
that had been provided and was known by the patient.
Finally, there also appears to be inconsistency in terms
of health professional knowledge, and advice given.
Knowledge
The present study showed that it is not only patients
with PAI who require knowledge of the condition,
replacement therapy, and importantly the adjustment of
glucocorticoids during intercurrent illness, but also the
support mechanisms the participants rely upon. These
include family, HCPs and voluntary.
Our study findings demonstrate that HCPs are seen as
experts in the knowledge and management of health
conditions by patients and family, and therefore it is
important that HCP’s knowledge is adequate and up to
date to diagnose and manage related life threatening
events, and complications [7].
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Findings from the present study confirm that partici-
pants received many differential diagnoses prior to the
establishment of the diagnosis of PAI. This resulted in
most patients having a treatment delay, which comes
with an increased risk of adrenal crisis, and this finding
is confirmed in the literature [20]. Educating health care
professionals is essential [21, 22].
The very fact that these diseases are rare means that
HCPs are unlikely to have encountered patients with the
condition. This is particularly true within the primary
care setting [23], where patients ultimately first present
with signs and symptoms of PAI. It is therefore not just
patients who need access to high quality information,
and demonstrates the importance of the HCP knowledge
in the diagnosis, management and continual support
that patients with rare diseases require [5, 24, 25].
It is acknowledged that only those living with a rare
condition will have the direct experience of how it
affects them and their family [25]. Subsequently, the
patient is seen as the expert. However, our study findings
demonstrate that patients look to HCPs for on-going
support in their journey, and shared decision making
between patients and HCPs is fundamental in healthcare
and aids both parties. It requires the medical problem to
be identified and reasonable options laid out, primarily
by the physician [26]. Although patients are responsible
to identify and convey their goals and concerns relevant
to the decision they are facing. In summary, patients and
healthcare professionals have an important role and
must be receptive to each other’s input.
Our findings demonstrated that during the healing
stage participants had accepted the diagnosis and had
adapted their lives to feel ‘ordinary again’. There is
strong evidence that engaged patients are more in-
formed and likely to fully consider risk and benefit of
different treatment options [26], although there is also
evidence that not all patients want to be involved in
healthcare decisions [27]. Therefore it is important to
consider that some patients will still rely on HCPs for
the guidance and support of the condition. Ultimately,
participants are responsible on a day-day basis for the
management of the condition.
Patient knowledge and application
Our study confirmed that patients have a good knowledge
base of how to adjust glucocorticoid treatment during
acute illness as shown by their responses to question 2 of
the interview schedule (Table 1), which contrasts a num-
ber of studies that have highlighted knowledge deficits of
adrenal insufficiency, crisis, management and prevention
[7, 28, 29]. However, what our findings do demonstrate is
that despite good knowledge, participants still experienced
adrenal crisis following diagnosis. This suggests thatknowledge does not translate into behaviour change,
resulting in a gap in knowledge-application. This is in
keeping with findings by Hahner et al. [6] and Van der
Meij et al. [30] who found education sessions do not
achieve sufficient self-management of glucocorticoid
replacement. It is important therefore to explore why
educated patients with PAI do not apply information
provided in times of need.
Documentation of the education provided to patients
This study showed that documentation in the medical
notes regarding the education provided to patients with
PAI was good but detail inadequate. That could be due
to the lack of an agreeable standardised format of
recording the different components of the education
given to the patient. However, the lack of recording may
not necessarily reflect lack of education as in our study
9/10 patients knew what to do in acute illness despite
the variable recording of the education information in
the medical records. Patients may receive education and
subsequently attain knowledge from a variety of other
sources other than the healthcare professional, for
example, the World Wide Web, self-help groups, family
and friends. This is supported by Sorensen et al. [31],
who found that errors in the data may reflect incorrect
data entry or lack of entry of available information. Also
while the original source of information may be cor-
rectly entered into the data source it may not reflect the
true condition or characteristic of the subject [31]. This
calls for improvement in the standardisation of docu-
mentation of patient education given.
Experience - the journey
The present study uniquely describes the patient’s
experience of a rare condition, PAI. They describe the
transitional journey within the context of ‘reeling’, ‘deal-
ing’ and ‘healing.’ These are similar concepts to those
described by Kubler-Ross [32] within the grief process
which include denial, anger, bargaining, depression and
finally, acceptance. Coping with a new diagnosis involves
implementation of strategies that enable one to assess,
reflect and adapt. Isla Pera et al. [33] report similar find-
ings in a study of people with type 1 diabetes mellitus.
The study describes patient and relatives experience as
an emotional reaction similar to that of the grief cycle.
The present study describes the initial disbelief and shock
participants feel when receiving the diagnosis. They begin
to establish ways of dealing with the diagnosis and treat-
ment regimens and incorporate this into their lives. Forss
et al. (2012) also found that glucocorticoid replacement
regimens impacted on patients’ lives and their self-
perceived outcomes, such as physical activity or family life
[34]. It is recommended HCPs talk about disease adapta-
tion rather than acceptance, since patients need to
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Pera et al. [33] study, health professionals related patient
poor adherence to denial of the disease, conversely patients
reported poor adherence related to the demands of treat-
ment and its impact on quality of life. However, there is a
link between reassurance and adaptation, and participants
of the present study valued and required on-going support
also highlighted by Boot et al. [35]. However, acceptation of
a disease and its limitations are a necessary step in the
adaptation process, and worried patients need reassur-
ance in order to achieve adaptation [35]. In the present
study it was interesting to note that patients reported
receiving reassurance from family rather than health-
care professionals when dealing with the condition day
to day and in times of crisis.
The present study participants felt overwhelmed and
isolated during the ‘dealing’ stage and sought to find
answers. Failure from healthcare professionals to react
appropriately, led to patients feeling isolated. Partici-
pants either wore or carried something identifying they
were taking steroids. Wearing of medical identification
jewellery is recommended [2, 10], and provides emer-
gency HCPs responsible for the urgent care of a patient
with PAI, with critical information that will guide
additional assessments and medical interventions. The
prevalence of patients with chronic disorders who use
medic alert jewellery is unknown [36] and available data
is paediatric focused [36, 37]. However, patients’ view of
medical alert jewellery varies [37, 38]. Some see them-
selves as ‘belonging’ to a particular special group and
therefore view it as positive, for others it is negative,
being viewed as ‘different’ from others, and labelled by a
diagnosis, which can lead to isolation [38].
Turner & Kelly [39] state that the emotional dimensions
of chronic conditions are often overlooked when medical
care is considered. Since PAI is a chronic condition, HCPs
have a fundamental role in guiding patients and their
family through this transitional process, recognising the
multiple psycho-social dimensions of chronic disease in
order to address both their physical and emotional needs.
It is important to remember that the relationship between
the HCP, patient and family should be a continuum and
not time specific.
Limitations
The research was conducted in one NHS Trust and
therefore findings may not be generalisable to other
healthcare provider organisations. The sample size was
small, and does not represent the gender distribution of
PAI; larger samples are required to validate findings.
The impact of gender and age on our findings would be
an interesting area to explore in future studies as our
current sample size does not allow us sub-group ana-
lysis. Future research should also explore the impact ofage and disease duration and its effect on education and
prevention of adrenal crisis. It is not known how many
healthcare providers educated the patients over the
course of the patients care.
The lead researcher who also was the interviewer was
known to participants and therefore it is important to
consider this relationship and its potential impact. There
are numerous kinds of relationships that might enter
into qualitative research; therefore, it is essential not to
‘hide behind the mask of rapport’ or the ‘wall of profes-
sional distancing’ [40]. As qualitative researchers we
must be trustworthy, transparent and reflexive in com-
munications with participants and “honour the conse-
quence of acting with genuineness” [40] (p. 105).
Conclusion
This is the first study where patients have described
their experience of PAI as a transitional journey.
Although the study findings are not generalizable, it
highlights factors that influence the diagnosis and man-
agement of the condition. We found that provision and
receipt of patient knowledge does not necessarily result
in a behaviour change to apply the knowledge in times
of need; the reasons for which are currently unknown.
This lack of application of knowledge is likely to be
multifactorial including patient related factors and possibly
problems with interactions with healthcare professionals.
Future studies should explore the reasons underpinning
this lack of application in knowledge in order to develop
appropriate interventions.
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